One Health News

 
Search News:
 
Found 806 Matching Results. View archived News Here.

New AVMA president prioritizes leadership, workforce, One Health - Thursday, July 27, 2017

 

New AVMA president prioritizes leadership, workforce, One Health

Please read complete article http://www.veterinarypracticenews.com/New-AVMA-president-prioritizes-leadership-workforce-One-Health/

VetPracticeNews.com

Promoting veterinary leadership, addressing federal veterinary workforce shortages, and leading the One Health initiative are the top priorities for the ...

Google Plus

Facebook

Twitter

         From Google Alerts...


American Veterinarian - "AVMA 2017: Insights for One Health from Millenia Past - Tuesday, July 25, 2017

Google Alerts

AVMA 2017: Insights for One Health from Millennia Past

American Veterinarian

“We're all in this together” was the One Health–focused theme of paleontologist and explorer Paul Sereno's keynote address during the 2017 ...

Google Plus

Facebook

Twitter


“Insights for One Health from Centuries and Millennia Past” - Indiana Convention Center, Indianapolis, Indiana July 22, 2017 - Friday, July 21, 2017

Insights for One Health from Centuries and Millennia Past” -  Indiana Convention Center, Indianapolis, Indiana July 22, 2017 at 10:00 a.m. 

Saturday morning American Veterinary Medical Association (AVMA) convention at July 22, 2017 Keynote Brunch 10 a.m. http://atwork.avma.org/2017/01/27/keynote-speaker-paul-sereno-will-bring-the-past-to-life-at-avma-convention-2017/ at the Indiana Convention Center, Indianapolis, Indiana.

Paul Sereno https://en.wikipedia.org/wiki/Paul_Sereno

 

Keynote speaker Paul Sereno will bring the past to life at AVMA Convention 2017

Attendees at AVMA Convention 2017 will have the opportunity to join renowned paleontologist Paul Sereno at AVMA Convention 2017 for a keynote presentation exploring how the history of the animal world relates to modern veterinary medicine. His keynote brunch address, “Insights for One Health from Centuries and Millennia Past,” promises to bring a modern angle to ancient history.

New developments in genetics, ancient DNA, fossil discoveries, and research into human development are changing our perspective on what actually happened in the past. From human-animal health crises to the timing of evolutionary changes, Sereno will bring ancient history alive to inform our current veterinary work.

Paul Sereno is a National Geographic Explorer and internationally acclaimed professor at the University of Chicago who has explored the Sahara and Gobi Deserts, India’s Thar Desert and remote valleys in Tibet. His work is an exciting blend of art, history and science wrapped in adventure, and we’re excited that he has agreed to give this keynote presentation at AVMA Convention 2017.

The keynote brunch will take place on Saturday, July 22, at 10 A.M., and is open to full convention registrants including veterinarians, technicians, practice staff and students. Guests and exhibitors are invited to attend a viewing party in an alternate location.

Interested in attending AVMA Convention 2017? You can learn more about convention events and CE highlights, and book your hotel room now, at avmaconvention.org. Registration will open in February, so Follow AVMA Convention on Twitter and Facebook for the latest updates.

Note: The American Veterinary Medical Association, founded in 1863, is a not-for-profit association representing more than 89,000 U.S. veterinarians working in private and corporate practice, government, industry, academia, and uniformed services.


Associated One Health initiatives - Monday, July 17, 2017

Network for Evaluation of One Health http://neoh.onehealthglobal.net/

Associated One Health initiatives

“The national, international and global One Health initiatives and consortia described here are directly or indirectly associated with NEOH and form part of the global One Health ...”

SEE http://neoh.onehealthglobal.net/associated-one-health-initiatives/


UC Davis (USA) Commentary on G-20 Nations recommend adopting One Health Approach for Antimicrobial Resistance (AMR) - Wednesday, July 12, 2017

Michael Lairmore, Dean, Veterinary Medicine

Dean's Musings

Addressing Societal Needs by Combating Antimicrobial Resistance

By Michael Lairmore On July 11, 2017

 “Infectious disease exists at this intersection between real science, medicine, public health, social policy, and human conflict.” – Andrea Barrett

As part of our school’s vision, we seek to address societal needs. In challenging ourselves to this daunting task of working to solve the most vexing problems our world faces, we find our people and programs drawn toward the interface of science, public health, and policy. In opening remarks at the recent G20 Conference, Angel Gurría, Secretary-General of the Organization for Economic Co-operation and Development, praised Germany Chancellor Angela Merkel for recognizing that antimicrobial resistance (AMR) is a major threat to the health of the world’s populations and the future of economies of the many countries.

He indicated that as many as 700,000 people worldwide are already dying each year because of drug-resistant infections and that the cumulative economic cost of AMR will reach 100 trillion dollars by 2050, a cost primarily borne by low and middle income countries. The Secretary-General went on to suggest that “by implementing existing international commitments and recommendations of the World Health Organization, Food and Agriculture Organization of the United Nations and World Organization for Animal Health, countries can promote a more appropriate use of antimicrobials in a true ‘One Health’ framework.”

Antimicrobial resistance is an example of a major societal issue that our school has been making significant efforts to understand and combat. These efforts include forming partnerships with state and national organizations to inform stakeholders on a new Food and Drug Administration Guidance on the use of antimicrobials, to working with the California Veterinary Medical Association and the California Department of Food and Agriculture to develop evidence-based science policies in California to ensure the proper use of antimicrobials to advance animal health, while not overusing important human drugs for growth promotion as feed additives.

Dr. Terry Lehenbauer, director of the UC Davis Veterinary Medical Teaching and Research Center in Tulare, participated in a recent American Public and Land-grant University/American Association of Veterinary Medical Colleges Working Group to develop antimicrobial resistance curriculum learning outcomes, which were featured at a U.S. Capitol Hill Briefing. We have successfully competed for a new cooperative extension specialist faculty position focused on antimicrobial resistance research and outreach. This new faculty member will join a comprehensive group of faculty members who are studying AMR from multiple vantage points to address this important health threat.

The California Animal Health & Food Safety Laboratory (CAHFS) in Tulare, a diagnostic laboratory devoted to protecting farm animals, the food supply and the public against new and emerging diseases. The Tulare facility is one of four labs in the California Animal Health and Food Safety Laboratory System, headquartered at UC Davis and operated for the state by the veterinary school to protect animal health and performance, and safeguard public health and the food supply.

Our California Animal Health and Food Safety laboratory diagnosticians and scientist are actively seeking ways to monitor drug-resistant bacteria in our food supply. Our scientists are using the latest technologies to genetically analyze food-borne pathogens, especially those that may be resistant to commonly used antibiotics. Our school has partnered with the Farm Foundation to bring together the state’s livestock and poultry producers, their feed suppliers and veterinarians to discuss the changing landscape of antibiotic drug use in food animals. Knowledge related to the proper use of antibiotics is then offered to our stakeholders throughout the State of California via our cooperative extension faculty through conferences, proceedings, and other public outreach efforts.

Collectively, our people and programs are on the front lines of counteracting AMR, exemplifying our vision to address this pressing societal need. In doing so, we are in lock-step with other G20 countries committed to promoting the appropriate use of antimicrobials through a One Health approach.

Please see link for full article:

http://lairvet.faculty.ucdavis.edu/2017/07/11/addressing-societal-needs-by-combating-antimicrobial-resistance/

Provided by: 

Michael D. Lairmore DVM, PhD

Dean and Distinguished Professor

School of Veterinary Medicine

University of California – Davis

One Shields Avenue

Davis, CA 95616

Tel (530) 752-1361

Fax (530) 752-2801

Email: mdlairmore@ucdavis.edu

Twitter: @LairmoreDVMDean

Note:  Dr. Lairmore is a longstanding One Health leader and champion https://goo.gl/y8MTrK.

 


G20 2017 Leaders’ Declaration: Shaping an interconnected world - Combatting Antimicrobial Resistance via a One Health Approach - Monday, July 10, 2017

G20 2017 Leaders’ Declaration: Shaping an interconnected world

--Combatting Antimicrobial Resistance via a One Health Approach--

From The Weekend Australian http://www.theaustralian.com.au/

SEE http://www.theaustralian.com.au/news/world/g20-2017-leaders-declaration-shaping-an-interconnected-world/news-story/27e752cd6768607df06e0f1569333cac or https://goo.gl/ZT65rf.

 

“Combatting Antimicrobial Resistance (AMR): AMR represents a growing threat to public health and economic growth. To tackle the spread of AMR in humans, animals and the environment, we aim to have implementation of our National Action Plans, based on a One-Health approach, well under way by the end of 2018. We will promote the prudent use of antibiotics (Noting differences in the G20 country definitions of the term “antibiotics” and referring here to those antibiotics with an impact on human health, including those antimicrobials that are critically important for human medicine as defined by the WHO.) in all sectors and strive to restrict their use in veterinary medicine to therapeutic uses alone. Responsible and prudent use of antibiotics in food producing animals does not include the use for growth promotion in the absence of risk analysis. We underline that treatments should be available through prescription or the veterinary equivalent only. We will strengthen public awareness, infection prevention and control and improve the understanding of the issue of antimicrobials in the environment. We will promote access to affordable and quality antimicrobials, vaccines and diagnostics, including through efforts to preserve existing therapeutic options. We highlight the importance of fostering R&D, in particular for priority pathogens as identified by the WHO and tuberculosis. We call for a new international R&D Collaboration Hub to maximise the impact of existing and new anti-microbial basic and clinical research initiatives as well as product development. We invite all interested countries and partners to join this new initiative. Concurrently, in collaboration with relevant experts including from the OECD and the WHO, we will further examine practical market incentive options.”

 


G20 nations pledge to strengthen health systems, combat antimicrobial resistance -via ONE HEALTH approach - Sunday, July 09, 2017

 

G20 nations pledge to strengthen health systems, combat antimicrobial resistance

The New Indian Express

SEE http://www.newindianexpress.com/world/2017/jul/09/g20-nations-pledge-to-strengthen-health-systems-combat-antimicrobial-resistance-1626153.html or https://goo.gl/s5f6Vk.

 

G20 nations pledge to strengthen health systems, combat antimicrobial ... of their respective national action plans based on "one health" approach.

G20 nations pledge to strengthen health systems, combat AMR - Outlook India

Full Coverage

Google Plus

Facebook

Twitter

 

Google Alert


Think “One Health in Action”...when you, a friend or a loved one needs an intracoronary artery (or bypass vein graft) stent(s) to survive! - Thursday, July 06, 2017

Think “One Health in Action”...when you, a friend or a loved one needs an intracoronary artery (or bypass vein graft) stent(s) to survive!

Reminder...

 

“ONE HEALTH in Action” - First Flexible Coil Balloon Expandable Intracoronary Stent Development for Humans – Posted One Health Initiative website Tuesday, February 09, 2010 https://goo.gl/2dTWV2.

“ONE HEALTH in Action” - First Flexible Coil Balloon Expandable Intracoronary Stent Development for Humans

 

The One Health initiative website has been advised by Peter G. Anderson, DVM, PhD, Professor & Director of Pathology Undergraduate Education and Pre-Clerkship Curriculum Coordinator at the Department of Pathology, University of Alabama at Birmingham (UAB) School of Medicine, that the “One Health Initiative” web link has been added to the front page of PEIR (http://peir.net).

 

Moreover, it should be noted that Dr. Peter G. Anderson, a veterinarian, represents a prime and significant historic example of “ONE HEALTH in Action”.  Dr. Anderson was part of the team that developed the first flexible coil balloon expandable intracoronary stent approved by the FDA for human use. This monumental development occurred in the early 1990’s and now – almost 100% of patients who undergo the balloon angioplasty procedure also get a stent. These stents can be coated with drugs to help the blood vessel heal after the balloon procedure to prevent scar tissue from forming leading to restenosis.  Today the drug coated stents that Dr. Anderson helped develop and holds a patent for are being used extensively to decrease morbidity and mortality in patients worldwide.

 

Gary Roubin, BVSc (equiv. DVM), MB (equiv. MD), PhD, an internationally renowned interventional cardiologist (currently at Lenox Hill Hospital in New York City, where he has been the Chairman of the Department of Interventional Cardiology and Director of the Cardiovascular Interventional Suites since 2004), worked to develop the first “balloon expandable intracoronary stent” used in the USA. Dr. Roubin came to the University of Alabama in 1989 where Dr. Anderson was the pathologist who participated in the animal studies using pigs. This animal data was sent to the FDA and eventually the stent was approved for human use.  Dr. Anderson says, “While we [i.e., Drs. Roubin and Anderson] were waiting for approval for the FDA – we did get a “provisional” approval to use the stents in people if it was a life threatening situation.  So, here at UAB we deployed many of the stents before they were formally approved by the FDA.” “And, I did the autopsies on the people who died after stent implantation”, said Dr. Anderson. “So, with Gary Roubin as corresponding author, we published the first paper describing the pathology of these balloon expandable flexible coil stents in people.”

 

Dr. Anderson went on to say, “Gary is the cardiologist who was the innovator in developing the stents [Gianturco-Roubin Flex Stent] and has continued to be an internationally recognized leader in interventional cardiology.  An interesting side note – Gary Roubin was originally from Australia. He started out as a veterinarian – then he went back to school to be a physician, received a PhD degree in physiology, trained in cardiology and then he came to the U.S.  So, Gary Roubin started out as a veterinarian and then went on to be an internationally renowned interventional cardiologist.”


Prominent Infectious Diseases Physician—Dr. Larry I. Lutwick—Endorses One Health paradigm - Sunday, July 02, 2017

Prominent Infectious Diseases Physician—Dr. Larry I. Lutwick—Endorses One Health paradigm

 

“As an academically trained Infectious Diseases physician with 40 years of experience, the need for intense cooperation between animal and human medicine is becoming more and more vital.  Not that zoonotic infections are new but they are becoming more and more relevant in emerging and reemerging diseases.  From the threats of the avian influenzas such as H5N1 and H7N9 to cause pandemics in man to new species jumping infections such as SARS and MERS and "old ones" such as plague, tularemia and Q fever to new scenarios such as certain genotypes of hepatitis E which are zoonotic and can cause chronic human infection in immunocompromised hosts, cooperation is vital to minimize the impact of all of those and more infectious diseases.

Besides the necessities of basic science and clinical interactions between animal and human health, clinical scholars such as myself serve as a source of information about One Health to the medical and veterinary trainees to assist them in understanding the scope of these issues.  There is no doubt that the presence of the One Health paradigm and its supporters play a vital role in early detection, early prevention, treatment and education about the new world of the "Brave New World" of zoonotic infections.”

 

LARRY I. LUTWICK, MD, FACP

Moderator

Program for Monitoring Emerging Diseases

promed@promedmail.org 

lutwick@promedmail.org

Editor-in-Chief

ID Cases

Open Access ID clinical journal – Elsevier

www.journals.elsevier.com/idcases/


The 5th International One Health Congress - Saskatoon, Canada - June 22-25, 2018 - Thursday, June 29, 2017

cid:image001.jpg@01D2EFC6.E2AFF0B0

 

https://onehealthplatform.com/node/225

Provided by:

ONE HEALTH PLATFORM
It’s all connected
Chris Vanlangendonck

co-founder / management

0032 475 81 38 59
www.onehealthplatform.com


 
One Health Initiative
Home | About One Health | Mission Statement | One Health News | AVMA Task Force Report | One Health Newsletter |
Publications | Supporters | Supporter Endorsements | Upcoming Events | Contact Us